REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/18/2025
Back to search
Official data from USPTO
CENTOPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CENTOPHARMA
ST13
US500000088546263Class
5, 9, 35, 42, 44
Filing
88546263
Registration
6127982
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
08/19/2025
Trademark type
Word
Nice classes
5, 9, 35, 42, 44
Filing date
07/29/2019
Registration date
08/18/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/18/2020
Last transaction
08/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
16
Owner location
ROSTOCK, DE
Examiner
ALAO, OREOLUWA
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CENTOGENE GMBH
Centogene AG
Representatives
Angela P. Doughty WARD AND SMITH, P.A.
Technical classification
Nice Classes
Class 5Class 9Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for hereditary diseasesmetabolic diseasesoncological diseasescomplex multigenic diseases and veterinary preparations for hereditary diseasesmetabolic diseasesoncological diseasescomplex multigenic diseases; diagnostic preparations for medical purposes; chemical preparations for analyses in laboratoriesfor medical and veterinary purposesnamely for detecting genetic predispositions; chemical preparations for analyses in laboratoriesfor medical or veterinary purposesnucleic acid and chemical reagents; biological preparations for medical purposes for the treatment of hereditary diseasesmetabolic diseasesoncological diseases and complex multigenic diseases; Cultures of microorganisms for medical or veterinary use
Class 9
Scientificsurveyingweighingmeasuring and checking apparatus and instrumentsfluorometersspectrophotometersreal-time polymerase chain reaction (PCR) devices for gene expression and genotypingDNA analyzersDNA fragmentation and capture devicesthermal cyclerthermal blocks for incubations all to determine the structurecomposition or sequence of DNA on multiple genes or on the whole genomic coding region or the whole genometo determine structurecomposition or sequence of RNA and for biochemical measurements of biomarkers; apparatus and instruments for scientific research in laboratoriesscientific devices to determine DNA or RNA sequencealterationsrearrangementscopy number variationsdeletions; apparatus and instruments for scientific research in laboratoriesdevices to determine biochemical markersfluorometersspectrophotometersreal-time polymerase chain reaction (PCR) devices for gene expression and genotypingDNA analyzersDNA fragmentation and capture devices all for scientific purposes; apparatus and instruments for scientific research in laboratoriesdevices to prepare respective biological samples for acquiring measurementsthermal cyclersthermal blocksmagnetic beadspipetting tipsmicrocentrifuge tubes96-well microplates; pre-recorded compact discsDVDsother digital recording mediadownloadable audio and video digital recordingsdigital video mediaall featuring clinical phenotypicgenetic molecular and demographic information; computers; downloadable computer software for database management and for managinganalyzinginterpreting and storing the data obtained from laboratory instruments
Class 35
Collating and systematic ordering of data in a computer databasedatabase management and computerized file management; Computerized file management; Industrial analysis servicesindustrial management consultation including cost/yield analyses and marketing research services
Class 42
Scientific and technological services namelygenetic and biochemical analytical testing for scientific research purposes and new product research and design relating thereto; Industrial analysis services and provision of research services in the field of genetics and in the field of pharmaceutical development; Scientific research for medical purposes in the field of hereditary diseasesoncologycomplex genetics related diseases; Design and development of computer hardware and computer software; Services of a medical laboratory; medical laboratory services for the analysis of samples taken from patients; Provision of information in the field of pharmacology; providing online non-downloadable computer software for database management and for managinganalyzinginterpreting and storing the data obtained from laboratory instruments
Class 44
Medical and veterinary servicesin particularmedical analysis in connection with the treatment of individuals; Providing information in the fields of medicine and veterinary medicine; Health center servicesgenetic centers providing medical diagnosticpreventive and curative therapy services for genetic disorderscancer treatment centersrare disease treatment centerschildren's hospitals and women's hospital; Medical clinic services; medical clinic servicesmedical testing of bloodbiological tissuesalivaurine and hair follicles; gene therapy services in the field of oncologyinfertilityprenatal diagnosticscarrier testinggenetically inherited diseases
Publications
History of USPTO decisions and trademark events.
24 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/11/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
08/18/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/02/2020
PUBO
PUBLISHED FOR OPPOSITION
06/02/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/13/2020
ALIE
ASSIGNED TO LIE
04/28/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/22/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
04/21/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/21/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
04/21/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/21/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/11/2020
GNFR
FINAL REFUSAL E-MAILED
02/11/2020
CNFR
FINAL REFUSAL WRITTEN
02/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/17/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/17/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/17/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/25/2019
GNRT
NON-FINAL ACTION E-MAILED
09/25/2019
CNRT
NON-FINAL ACTION WRITTEN
09/25/2019
DOCK
ASSIGNED TO EXAMINER
09/18/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/08/2019
NWAP
NEW APPLICATION ENTERED
08/01/2019
Continuous trademark protection
Get notified about every new filing that threatens CENTOPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.